Structure‐based pharmacophore modeling for precision inhibition of mutant <scp>ESR2</scp> in breast cancer: A systematic computational approach

Abstract

Based on MD simulations and MM-GBSA analysis, our study identified ZINC05925939 as a promising ESR2 inhibitor among the top four hits. However, it is essential to conduct further wet lab evaluation to assess its efficacy.